KBI Global Investors’s Gilead Sciences GILD Stock Holding History

KBI Global Investors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$21.3M	Buy	+254,839	New	+$22.6M	0.57%	62

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

KBI Global Investors's GILD Position: Q2 2016 in Review

KBI Global Investors opened a new position in Gilead Sciences (GILD) in Q2 2016: 254,839 shares worth $21.3M. The stake represents 0.57% of the portfolio and ranks #62 among its holdings.

1,597 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

KBI Global Investors held 254,839 shares of Gilead Sciences worth $21.3M as of Q2 2016.
Gilead Sciences was a new KBI Global Investors position in Q2 2016.
Gilead Sciences made up 0.57% of KBI Global Investors's portfolio in Q2 2016, its #62 holding.
1,597 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on KBI Global Investors's 13F filing for Q2 2016, filed 3 Aug 2016.